BIOLOGICAL · Unmapped registry intervention
AN-1792 also known as AIP-001
Find medicine records ·
Find other trials using this name
Clinical trial
Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
NCT00021723
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRandomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
AN-1792 also known as AIP-001BIOLOGICAL
Sponsors & collaborators
Mapped research locations
HoustonTexas, United States1PhoenixArizona, United States1RochesterMinnesota, United States1La JollaCalifornia, United States1Fort LauderdaleFlorida, United States1TulsaOklahoma, United States1Boca RatonFlorida, United States1Beverly HillsCalifornia, United States1NorthridgeCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00021723 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.